eIF3 β Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of eIF3 β monoclonal antibodies for research in understanding cellular processes. eIF3 β Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF3 β, a critical component of the eukaryotic translation initiation factor 3 complex, plays a vital role in the regulation of protein synthesis by facilitating the recruitment of ribosomes to mRNA. The involvement of eIF3 β in translation initiation makes it essential for cellular growth and proliferation, and research has linked eIF3 β to various diseases, including cancer. Understanding eIF3 β function and regulation provides insights into gene expression mechanisms and supports the development of therapeutic strategies. Researchers can explore translation initiation pathways using specific monoclonal antibodies conjugated with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC). Advanced research techniques and high-quality reagents enable detailed investigation of eIF3 β's role in normal cellular function and disease states. Santa Cruz Biotechnology monoclonal antibodies for eIF3 β support researchers worldwide in advancing scientific knowledge and developing potential therapeutic applications.